News

Smarter Medicaid practices could save billions

BY Jim Frederick

The economic crisis and budget shortfalls have federal and state governments scrambling to cut healthcare costs in Medicaid and other programs. But some of the most effective tools for saving healthcare costs are right in front of budget-cutters and are relatively easy to implement, the National Association of Chain Drug Stores told policy-makers recently.

Among the most effective savings tools, said NACDS president and CEO Steve Anderson, is installing systems within the Medicaid payment and adjudication system that would encourage doctors and pharmacists to prescribe and dispense more low-cost generic drugs to patients enrolled in the massive federal health program. Boosting generic drug utilization alone would be a major source of cost savings, Anderson told leaders in Congress and the White House last month.

Combined with lower-cost “step” therapies and electronic prescribing, higher generic dispensing rates could help pharmacies cut more than $6 billion a year in Medicaid healthcare costs, Anderson said. He made that point in a letter to three of the most powerful national leaders influencing the shape of tomorrow’s healthcare system: Senate Finance Committee chairman Max Baucus, D-Mont., secretary of Health and Human Services Kathleen Sebelius and Nancy-Ann DeParle, director of the White House Office of Health Reform.

The retail pharmacy community, he told the officials, could help reduce healthcare costs and improve patient care to the tune of $6.38 billion in just the first year that Medicaid adopted efficiency standards, innovation and improved information and communications technology. “Community pharmacies are uniquely qualified to assist in efforts to reduce healthcare costs and improve health outcomes,” Anderson wrote. “Recognizing the importance of using the nation’s limited healthcare dollars wisely, NACDS has identified significant savings that could be achieved through the efficient structuring of pharmacy benefits and the appropriate use of medication.”

Greater utilization of generics, he noted, would yield big savings. Noting the “wide variation in the dispensing of generic drugs in state Medicaid programs,” Anderson pointed out that “the top five states nationwide have a generic dispensing rate of 72.7%, compared with the nationwide average of 65.1%.

In addition, as a result of inconsistent use of preferred drug lists, step therapy and other best practices, states also differ widely in what they pay for brand-name drugs,” Anderson added. “Five states with the lowest average brand-drug reimbursement, excluding rebates, have an average reimbursement for brand drugs of $183.29, compared with the national average of $204.54.”

Anderson pointed to several cost-saving steps the government could adopt to encourage cost-effective use of medications and cut Medicaid costs. Among them:

Increasing generic substitution rates to the levels employed by the top five states;

Mandating the use of e-prescribing;

Employing a stepped approach to medication therapy, “using lower-cost therapies before moving to more costly therapies;”

Requiring prior authorization for the prescribing and dispensing of high-cost drugs or drug classes; and

Encouraging, and paying for, drug utilization reviews, whereby pharmacists review patients’ medication profiles.

Anderson also urged expanded support of and funding for medication therapy management by retail pharmacists. “MTM has the potential to decrease healthcare costs by reducing adverse drug events and increasing compliance with medication regimens,” he told policy-makers.

“For example, the North Carolina ChecKmeds NC program, which offers eligible seniors one-on-one MTM consultations with pharmacists, saved an estimated $10 million in healthcare costs and avoided numerous health problems in the first year of the program for the more than 15,000 seniors receiving medication therapy management services,” Anderson added.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Kroger declares quarterly dividend

BY Michael Johnsen

CINCINNATI The Kroger Co. announced that its board of directors declared a quarterly dividend of 9 cents per share to be paid on Sept. 1 to shareholders of record at of the close of business on Aug. 14.

Kroger, one of the nation’s largest retail grocery chains, employs more than 326,000 associates, who serve customers in 2,475 supermarkets and multi-department stores in 31 states.

On Thursday, the company announced that its president and COO Don McGeorge was retiring. McGeorge has been replaced by W. Rodney McMullen.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Walgreens to test diabetes care model

BY DSN STAFF

NEW YORK Walgreens continues to flesh out its revamped strategy to be the nation’s most convenient and accessible provider of pharmacy and health-and-wellness services.

 

The latest plank in that platform is its plan to test a pharmacy-driven outreach and support program for patients with diabetes.

 

Diabetic-care services and product presentations are nothing new in the nation’s chain and independent drug stores; every pharmacy leader knows that diabetes is a major, (often undiagnosed) health challenge and a “gateway” disease that usually subjects its sufferers to a slew of other related conditions involving the circulatory system, the skin and other organs. It’s also no secret that diabetics generate far more in annual drug store sales to treat these related conditions.

 

What makes Walgreens’ pilot program worthy of notice are two things.

 

 

First, with some 6,800 retail pharmacies, 350 in-store and worksite clinics and a network of specialty pharmacies across the United States, the company wields enormous potential power in the healthcare marketplace. If it expands its fledgling diabetes pilot beyond the test stage, it has thousands of “points of care” through which it could offer diabetes support programs and other disease management offerings. It’s a huge potential resource to offer diabetic patients and their employer-based or government-sponsored health plans, not to mention those patients’ overburdened, time-constrained primary care doctors.

 

 

Second, Walgreens is very deliberately positioning its diabetes care offering as a part of a much broader, integrated healthcare platform that links patients in the program to all the company’s health-and-wellness capabilities, said Walgreens CEO Greg Wasson. And it dovetails neatly with the Obama administration’s call for “more preventive care and better access,” in the words of Walgreens’ top manager.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?